Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Activation, Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02400281
What this trial is testing

Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Arog Pharmaceuticals, Inc. 28
Not applicableStudy completedNCT04154592
What this trial is testing

The Effect of Humeral Head Depressor Muscle Co-Activation Training in Terms of Functional Outcomes

Who this might be right for
Rotator Cuff TearsSurgery
Hacettepe University 24
Large-scale testing (Phase 3)WithdrawnNCT01733134
What this trial is testing

Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)

Who this might be right for
Acute Heart Failure
Maisel, Alan, M.D.
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)WithdrawnNCT00022230
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT03843775
What this trial is testing

Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Who this might be right for
Advanced BRAF Mutant Cancers
Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07091136
What this trial is testing

Exploration of Manidipine to Reverse Aortic Valve Calcification

Who this might be right for
Calcific Aortic Valve Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100
Large-scale testing (Phase 3)Study completedNCT00348101
What this trial is testing

Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation

Who this might be right for
Coronary Artery Disease
Klinikum Ludwigshafen 75
Post-approval studies (Phase 4)WithdrawnNCT04936971
What this trial is testing

Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response

Who this might be right for
Kidney TransplantationCytomegalovirus Infections
Edoardo Melilli
Testing effectiveness (Phase 2)Ended earlyNCT04631744
What this trial is testing

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 4
Testing effectiveness (Phase 2)UnknownNCT01920204
What this trial is testing

Midostaurin in Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
University Medical Center Groningen 20
Not applicableStudy completedNCT05642065
What this trial is testing

Hip Activation and FSDT

Who this might be right for
Movement, AbnormalLower Extremity Problem
Louisiana State University Health Sciences Center Shreveport 35
Not applicableNot Yet RecruitingNCT07657117
What this trial is testing

Telestroke Triage in Suspected Stroke Patients

Who this might be right for
Stroke
Nyika D. Kruyt 518
Very early researchLooking for participantsNCT07475182
What this trial is testing

Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers

Who this might be right for
Advanced Solid Cancers
Hainan Cancer Hospital 10
Not applicableStudy completedNCT07669324
What this trial is testing

Effect of Chemical and Light Bleaching Techniques on Color Change, Dentin Hypersensitivity and Patient Satisfaction

Who this might be right for
Dentin Hypersensitivity
Nahda University 30
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT02544997
What this trial is testing

A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway

Who this might be right for
Metastatic Breast Cancer
Samsung Medical Center 5
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableNot Yet RecruitingNCT05900687
What this trial is testing

Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal RefluxPatient Activation
Stanford University 150
Testing effectiveness (Phase 2)Study completedNCT01069133
What this trial is testing

Study of Rifaximin in Minimal Hepatic Encephalopathy

Who this might be right for
Minimal Hepatic Encephalopathy
Hunter Holmes Mcguire Veteran Affairs Medical Center 20
Next Page